These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9161437)

  • 1. [Fluoroquinolones. Pharmacokinetic properties and new pharmacodynamic concepts].
    Bergogne-Bérézin E
    Presse Med; 1997 Apr; 26(12):577-82. PubMed ID: 9161437
    [No Abstract]   [Full Text] [Related]  

  • 2. Aqueous and vitreous penetration of topically applied ciprofloxacin and ofloxacin.
    Taustine LR
    J Cataract Refract Surg; 2004 Jan; 30(1):6. PubMed ID: 14967251
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of ciprofloxacin and ofloxacin using human corneal susceptibility levels.
    Kowalski RP; Karenchak LM; Gordon YJ
    Cornea; 1998 May; 17(3):282-7. PubMed ID: 9603384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
    Mattina R; Bellotti M; Raimondi A; Sander K
    Chemioterapia; 1987 Jun; 6(2 Suppl):302-3. PubMed ID: 3334569
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic drug monitoring of fluoroquinolone].
    Matsumoto F; Takahashi T; Morita M
    Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin.
    Osato MS
    Adv Ther; 1999; 16(5):200-9. PubMed ID: 10915395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is the switch of fluoroquinolones from intravenous to oral administration useful in an intensive care unit? Economical approach].
    Turc J; Eve O; Tran Van D; Wey PF; Martinez JY
    Ann Fr Anesth Reanim; 2009 Feb; 28(2):179-80. PubMed ID: 19171451
    [No Abstract]   [Full Text] [Related]  

  • 8. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
    Yu-Speight AW; Kern TJ; Erb HN
    Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and binding kinetics of ciprofloxacin and ofloxacin in the hindlimb of the rat.
    Sanchez-Navarro A; Casquero-Dorado AC; Weiss M
    Pharm Res; 1999 Apr; 16(4):587-91. PubMed ID: 10227717
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
    Daniel JP; Moulin B; Christmann D
    Ann Pharm Fr; 2004 May; 62(3):177-85. PubMed ID: 15243351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sex on the pharmacokinetics of ciprofloxacin and ofloxacin.
    Konieczna L; Chmielewska A; Lamparczyk H
    Chemotherapy; 2006; 52(3):111-21. PubMed ID: 16612053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Excretion of fluoroquinolones into saliva].
    Kelentey BA; Kelentey BJ; Fekete I; Kozma J
    Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes.
    Tillotson G; Zhao X; Drlica K
    Lancet Infect Dis; 2001 Oct; 1(3):145-6. PubMed ID: 11871490
    [No Abstract]   [Full Text] [Related]  

  • 14. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration.
    Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):465-8. PubMed ID: 10392734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1993 Jun; 38(6):66-78. PubMed ID: 8166571
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of topically applied ciprofloxacin in rabbit tears.
    Green LC; Callegan MC; Engel LS; Shimomura Y; Jasheway DW; O'Callaghan RJ; Hill JM
    Jpn J Ophthalmol; 1996; 40(1):123-6. PubMed ID: 8739510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD; D'Azevedo PA; Francisco W
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
    Polachek H; Holcberg G; Sapir G; Tsadkin-Tamir M; Polachek J; Katz M; Ben-Zvi Z
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):61-5. PubMed ID: 16154040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects.
    Cekiç O; Batman C; Totan Y; Yasar U; Basci NE; Bozkurt A; Kayaalp SO; Zilelioglu O
    Eye (Lond); 1999 Oct; 13 ( Pt 5)():656-9. PubMed ID: 10696321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.